EQ (Equillium, Inc.) Net Financial Result

Corporate emblem and logo of equilliumbio.com (EQ)

Equillium, Inc. (EQ) financial performance demonstrates the impact of delegating early-stage testing to external partners. AI-powered robotic platforms automate protein modeling, while outsourcing antibody production minimizes capital expenditures. The profit trend on this chart highlights the efficiency of such a strategy, with the value -0.02 representing the current business yield.

Equillium Bio (EQ): Company Net Income from 07/04/2022 to 10/30/2026

Analytical breakdowns and data insights for company equilliumbio.com (EQ)

- stock price and consensus target price:
Price Performance Chart Equillium|EQ - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization EQ|EQ - Total Company Value
- shareholders' equity book value data:
Accounting Value per Share Equillium|EQ - Company Book Value|Market Cap to Net Assets Ratio equilliumbio.com|EQ - Cumulative Company Assets
- debt and liquidity details:
Total Debt to Capital Equillium, Inc.|EQ - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Equillium|EQ - Company Aggregate Debts|Debts to Book Value EQ|EQ - Company Long-Term Debts|Short-Term Debt Equillium|Critical Liquidity equilliumbio.com
- net income and valuation ratios data:
EQ - Net Income
Fundamental valuation:EQ Equillium Bio
Manufactured product of Equillium Bio

Utilizing external CDMO facilities for antibody synthesis allows Equillium, Inc. (EQ) to minimize capital expenditures, which is clearly reflected in the company's net profitability on the GURU.Markets platform. This indicator captures daily financial returns, separating fundamental growth from speculative noise and confirming the business's ability to scale sales without sacrificing efficiency, which is critical for assessing asset liquidity.

Direct competitors

argenx BVBA - Final Profit|BNTX (BioNTech SE) - Net Profit|Abivax Pharma (ABVX) - Net Financial Result|Company Net Income ADMA Biologics, Inc. (ADMA)|Net Income Protagonist Therapeutics, Inc. PTGX|Company Net Income Immunovant Corp IMVT|KNSA - Net Income|GRFS: Net Income|ADPT - Net Profit|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Company Profit AUPH|BCRX (BioCryst Pharmaceuticals Inc) - Net Profit|Company Net Income Vera Corp VERA|Net Profit DNTH|PHVS - Company Net Income|Company Net Income AbCellera Biologics Inc ABCL|Annual Net Income Tourmaline Bio Inc|PGEN: Net Income|PHAR - Net Profit|NKTR: Net Profit|UPB - Net Financial Result|Company Net Income Zenas Biopharma|Company Net Income IMNM|Company Net Income Gossamer Corp (GOSS)|Company Net Income KALV (KalVista Corp)|Net Profit SEPN (Septerna Inc)|Net Financial Result pieris.com (PVLA)|SVRA: Net Income|RIGL - Net Profit|AnaptysBio Corp (ANAB) - Company Net Income|Net Income Astria Corp|Net Income ENGN|RAPT: Final Profit|Net Profit JBIO|Net Financial Result Aclaris Therapeutics Inc.|Company Net Income Kyverna KYTX|TLSA: Company Profit|Cabaletta Bio, Inc. - Net Profit|ventyxbio.com (VTYX) - Net Income|THTX (Theratechnologies) - Net Income|AVTX - Net Financial Result|ELDN (Eledon) - Net Profit|Company Net Income Agenus, Inc AGEN|Company Net Income Climb Bio Inc (CLYM)|zurabio.com (ZURA) - Annual Net Income|Company Net Income aTyr Pharma ATYR|ADAG (Adagene Inc) - Profit After Tax|Ikena Oncology, Inc. - Net Profit|Final Profit STTK (Shattuck Labs, Inc.)|CNTB: Net Profit|Immunic (IMUX) - Net Profit|Company Net Income Atara Biotherapeutics, Inc.|IFRX: Final Profit|Company Net Income X4 Pharma (XFOR)|Net Income adicetbio.com ACET|Net Profit CELU (Celularity)|Net Profit inmunebio.com INMB|BRNS: Net Income|Final Profit KZR (Kezar Life Sciences Inc.)|SABS: Net Profit|AKTX - Net Financial Result|Company Net Income Enlivex Therapeutics Ltd|Net Income Q32 Bio Corp (QTTB)|Company Net Income GeoVax (GOVX)|Net Income Edesa Biotech Inc EDSA|iBio Corp - Net Income|Net Profit Carisma Therapeutics Inc CARM|XTLB - Company Net Income|BOLT (Bolt Biotherapeutics) - Company Profit|HCWB: Net Profit|Company Net Income Aptevo Therapeutics Inc. (APVO)|AIM (AIM ImmunoTech) - Net Profit|Company Net Income Aditxt Corp ADTX|Company Net Income GRI Bio, Inc. (GRI)|xortx.com (XRTX) - Annual Net Income|Vyome Holdings - Net Income|Net Profit Revelation Biosciences Inc REVB|Indaptus - Net Profit|Net Financial Result BiondVax Pharmaceuticals SCNI|calcimedica.com (CALI) - Company Net Income|AFMD (Affimed N.V.) - Company Net Income|Company Net Income Allakos Inc|Company Net Income HOOK|Net Profit IGMS|Net Financial Result iTeos Pharma|Ocean Biomedical, Inc. - Net Income|Net Profit tcbiopharm.com TCBP|THRD - Company Net Income